Kevin Fitzmaurice

Senior Director, Technical Operations at Trevi Therapeutics - New Haven, CT, US

Kevin Fitzmaurice's Contact Details
HQ
203-304-2499
Location
Middlebury, Connecticut, United States
Company
Trevi Therapeutics
Kevin Fitzmaurice's Company Details
Trevi Therapeutics logo, Trevi Therapeutics contact details

Trevi Therapeutics

New Haven, CT, US • 20 - 49 Employees
BioTech/Drugs

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.

B2B Biotechnology Healthcare Pharmaceuticals Major Drugs Commercial Physical Research
Details about Trevi Therapeutics
Frequently Asked Questions about Kevin Fitzmaurice
Kevin Fitzmaurice currently works for Trevi Therapeutics.
Kevin Fitzmaurice's role at Trevi Therapeutics is Senior Director, Technical Operations.
Kevin Fitzmaurice's email address is ***@trevitherapeutics.com. To view Kevin Fitzmaurice's full email address, please signup to ConnectPlex.
Kevin Fitzmaurice works in the BioTech/Drugs industry.
Kevin Fitzmaurice's colleagues at Trevi Therapeutics are Lisa Delfini, Dawn Newmin, Katie McManus, Lauren Waggoner Kriss, Lori Iwanicki, Lara Lewkowicz, Rebecca Morse and others.
Kevin Fitzmaurice's phone number is 203-304-2499
See more information about Kevin Fitzmaurice